Study: NCT05609370

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LBL-007
Description: Administered intravenously.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LBL-007
Description: Administered intravenously.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LBL-007
Description: Administered intravenously.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LBL-007
Description: Administered intravenously.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LBL-007
Description: Administered intravenously.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LBL-007
Description: Administered intravenously.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: LBL-007
Description: Administered intravenously.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Administered intravenously.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Administered intravenously.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Administered intravenously.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Administered intravenously.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Administered intravenously.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tislelizumab
Description: Administered intravenously.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab or Bevacizumab biosimilar
Description: Administered intravenously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab or Bevacizumab biosimilar
Description: Administered intravenously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab or Bevacizumab biosimilar
Description: Administered intravenously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab or Bevacizumab biosimilar
Description: Administered intravenously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab or Bevacizumab biosimilar
Description: Administered intravenously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab or Bevacizumab biosimilar
Description: Administered intravenously

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bevacizumab or Bevacizumab biosimilar
Description: Administered intravenously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Administered in accordance with relevant local guidelines and/or prescribing information

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Administered in accordance with relevant local guidelines and/or prescribing information

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Administered in accordance with relevant local guidelines and/or prescribing information

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Administered in accordance with relevant local guidelines and/or prescribing information

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Administered in accordance with relevant local guidelines and/or prescribing information

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Capecitabine
Description: Administered in accordance with relevant local guidelines and/or prescribing information

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil
Description: Administered in accordance with relevant local guidelines and/or prescribing information

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil
Description: Administered in accordance with relevant local guidelines and/or prescribing information

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil
Description: Administered in accordance with relevant local guidelines and/or prescribing information

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil
Description: Administered in accordance with relevant local guidelines and/or prescribing information

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5-Fluorouracil
Description: Administered in accordance with relevant local guidelines and/or prescribing information